These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1763769)

  • 1. DdI for AIDS patients intolerant to AZT.
    Am Pharm; 1991 Dec; NS31(12):10. PubMed ID: 1763769
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM; Bechtel LM; Starich GH
    Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.
    Vella S; Floridia M; Dally LG; Tomino C; Fragola V; Weimer LE; Milazzo F; Mazzotta F; Moroni M; Pastore G; Scalise G; Sinicco A; Ortona L; De Rienzo B; Dianzani F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):462-9. PubMed ID: 8757422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT).
    Moyle GJ; Nelson MR; Hawkins D; Gazzard BG
    Q J Med; 1993 Mar; 86(3):155-63. PubMed ID: 8387218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS treatment: 'parallel trick' for ddI.
    McGourty C
    Nature; 1989 Oct; 341(6242):474. PubMed ID: 2507927
    [No Abstract]   [Full Text] [Related]  

  • 6. AZT delta study: major European/Australian study finds combinations better than AZT alone.
    King E
    AIDS Treat News; 1995 Oct; (no 232):3-4. PubMed ID: 11362876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study results at a glance.
    AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTG 175 and Delta.
    Torres G
    GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies confirm value of early and combination treatments.
    Vazquez E
    Posit Aware; 1995; VI(6):8. PubMed ID: 11363148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypokalemia and hypomagnesemia on zidovudine (AZT) and didanosine (ddI) nephrotoxicity in rats.
    Seguro AC; de Araujo M; Seguro FS; Rienzo M; Magaldi AJ; Campos SB
    Clin Nephrol; 2003 Apr; 59(4):267-72. PubMed ID: 12708566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second AIDS drug approved for those who can't tolerate AZT.
    Oncology (Williston Park); 1991 Nov; 5(11):103. PubMed ID: 1837223
    [No Abstract]   [Full Text] [Related]  

  • 13. [The acquired immunodeficiency syndrome (AIDS) in childhood].
    Terragna A; Ferrazin A; Gotta C; Wenda-Ciravegna B
    Medicina (Firenze); 1990; 10(3):256-62. PubMed ID: 1964193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The drugs 2',3'-dideoxyinosine (ddI) and 2',3'-dideoxycytidine (ddC) are safe alternatives in people with AIDS with zidovudine-induced myopathy.
    Jay C; Ropka M; Dalakas MC
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):630-1. PubMed ID: 8176648
    [No Abstract]   [Full Text] [Related]  

  • 15. Data and safety monitoring in the Concorde and Alpha trials.
    Armitage P
    Control Clin Trials; 1999 Jun; 20(3):207-28. PubMed ID: 10357495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS drug update: DDI and DDC.
    Anastasi JK; Rivera JL
    RN; 1991 Nov; 54(11):41-3. PubMed ID: 1658917
    [No Abstract]   [Full Text] [Related]  

  • 17. ddI--a good start, but still phase I.
    Fauci AS
    N Engl J Med; 1990 May; 322(19):1386-8. PubMed ID: 2109198
    [No Abstract]   [Full Text] [Related]  

  • 18. New drug therapy for patients with HIV. Nursing implications in the administration of 2',3'-dideoxyinosine (ddI).
    Shay LE; Thomas RV; Wyvill KM; Adamo DO; Jenkins JF
    Cancer Nurs; 1990 Oct; 13(5):269-77. PubMed ID: 2123127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HIV treatment on cognition, behavior, and emotion.
    Katz MH
    Psychiatr Clin North Am; 1994 Mar; 17(1):227-30. PubMed ID: 8190667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of didanosine in the management of HIV-1 infection.
    Gazzard BG; Moyle GJ
    Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.